---
title: "Mangoceuticals Q2 net loss narrows to $1.31 million; revenue drops 59.11% to $68,757"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295850133.md"
description: "Mangoceuticals reported a narrowed Q2 net loss of $1.31 million, down from $5.42 million year-over-year, despite revenue dropping 59.11% to $68,757. General and administrative expenses and stock-based compensation also decreased significantly. For the first half of the year, the net loss narrowed to $4.72 million. Additionally, the company entered a business combination agreement with Nuclea Energy on July 29."
datetime: "2026-08-13T21:28:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295850133.md)
  - [en](https://longbridge.com/en/news/295850133.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295850133.md)
---

# Mangoceuticals Q2 net loss narrows to $1.31 million; revenue drops 59.11% to $68,757

-   Mangoceuticals posted Q2 net loss of USD 1.31 million, narrowing from USD 5.42 million a year earlier. \* Revenue fell 59.11% to USD 68,757 from the prior-year quarter. \* General and administrative expense dropped to USD 256,095 from USD 1.25 million; stock-based compensation sank to USD 92,417 from USD 3.12 million. \* Six-month net loss narrowed to USD 4.72 million from USD 10.26 million; revenue declined to USD 136,621 from USD 277,415. \* Entered a business combination agreement with Nuclea Energy on July 29, targeting a structure leaving former Nuclea holders about 96% ownership. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037873), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MGRX.US](https://longbridge.com/en/quote/MGRX.US.md)

## Related News & Research

- [Mangoceuticals advances Nuclea Energy business combination agreement](https://longbridge.com/en/news/294876784.md)
- [Mangoceuticals signs business combination deal with Nuclea Energy](https://longbridge.com/en/news/294351789.md)
- [14:46 ETUniversity of Phoenix student survey points to responsible use, judgment and real-world practice as foundations of AI readiness](https://longbridge.com/en/news/296260376.md)
- [Svolder net asset value holds at SEK 59 per share as of Aug. 14](https://longbridge.com/en/news/296062065.md)
- [GDS publishes transcript of Q2 2026 earnings call](https://longbridge.com/en/news/295886628.md)